Healthcare lies at the confluence of science, clinical practice, and regulation. I analyze trends, data, and diseases with eye toward biotech and a touch of humor
Engineer, Investor, Future Clinician
Writing about medicine, biology, stats, and anything in between. Commentary on new medical research, clinical trials, and biotech companies.
Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.